Bioalert

Bioalert

Real-time mobile notification service for biotech investors

1 follower

Investing in biotech companies requires up-to-date information for key moves. Bioalert constantly monitors press releases, FDA approvals, SEC filings, and social media streams. Filters important updates and sends mobile notifications immediately.

Bioalert launches

Launch date
Bioalert
Bioalert Real-time mobile notification service for biotech investors

Launched on January 30th, 2022